Get the Stockscreener App
148.41
2.43%
-3.70
Pre-market:
148.00
-0.41
-0.28%
Irhythm Holdings Inc stock is traded at $148.41, with a volume of 680.29K.
It is down -2.43% in the last 24 hours and down -12.18% over the past month.
iRhythm Holdings Inc formerly, iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
See More
Previous Close:
$152.11
Open:
$153.51
24h Volume:
680.29K
Relative Volume:
1.19
Market Cap:
$4.78B
Revenue:
$560.03M
Net Income/Loss:
$-150.66M
P/E Ratio:
-30.54
EPS:
-4.86
Net Cash Flow:
$-87.43M
1W Performance:
+1.13%
1M Performance:
-12.18%
6M Performance:
-8.59%
1Y Performance:
+33.50%
1-Day Range:
$147.71
$157.28
1-Week Range:
$144.79
$157.28
52-Week Range:
$92.52
$212.00
Irhythm Holdings Inc Stock (IRTC) Company Profile
Name
Irhythm Holdings Inc
Sector
Industry
Phone
415-632-5700
Address
699 8TH STREET, San Francisco, CA
Compare IRTC vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRTC
Irhythm Holdings Inc
|
148.41 | 4.90B | 560.03M | -150.66M | -87.43M | -4.86 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-23-25 | Initiated | Evercore ISI | In-line |
| Aug-20-25 | Initiated | BofA Securities | Buy |
| May-02-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-03-24 | Resumed | Wells Fargo | Equal Weight |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Jun-20-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Feb-07-23 | Initiated | Wells Fargo | Overweight |
| Nov-07-22 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-06-22 | Initiated | Wolfe Research | Underperform |
| Feb-24-22 | Upgrade | Needham | Hold → Buy |
| Jan-18-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-12-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-11-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-21-21 | Resumed | Canaccord Genuity | Buy |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Jun-02-21 | Downgrade | Citigroup | Buy → Neutral |
| Apr-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Colliers Securities | Buy → Neutral |
| Jan-29-21 | Reiterated | Needham | Hold |
| Nov-17-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-11-20 | Initiated | Needham | Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Aug-07-20 | Upgrade | Colliers Securities | Neutral → Buy |
| Aug-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-10-20 | Initiated | William Blair | Outperform |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Perform |
| Feb-20-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Sep-13-18 | Reiterated | Canaccord Genuity | Buy |
| Sep-06-18 | Initiated | Chardan Capital Markets | Buy |
| Aug-02-18 | Upgrade | Dougherty & Company | Sell → Neutral |
| Jul-16-18 | Downgrade | Dougherty & Company | Neutral → Sell |
| Dec-01-17 | Initiated | Dougherty & Company | Neutral |
View All
Irhythm Holdings Inc Stock (IRTC) Latest News
iRhythm Holding Company Shift Raises Questions On Valuation And Governance - Yahoo Finance
iRhythm Reorganization Raises Questions On Valuation And Shareholder Position - simplywall.st
Will iRhythm Technologies Inc. (I25) stock announce special dividendEarnings Trend Report & Real-Time Price Movement Reports - mfd.ru
iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 - The Manila Times
Silvercrest Asset Management Group Inc. Announces Quarterly Dividend - The Manila Times
2 Healthcare Stocks with Promising Prospects and 1 We Brush Off - Finviz
iRhythm Technologies (NASDAQ:IRTC) Sees Significant Growth in Short Interest - MarketBeat
iRhythm Holdings, Inc. (IRTC) Stock Analysis: Tapping into a 43% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
How The iRhythm Holdings (IRTC) Story Is Shifting With The Latest Price Target Reset - Yahoo Finance
Here is why hedge funds are appreciating iRhythm Holdings (IRTC) - MSN
iRhythm Holdings Restructures Into New Parent Company Reporting Framework - Yahoo Finance
Federated Hermes Inc. Has $12.11 Million Stock Position in iRhythm Technologies $IRTC - MarketBeat
iRhythm: Structural Shift To Profitable Growth (NASDAQ:IRTC) - Seeking Alpha
Y Intercept Hong Kong Ltd Sells 22,037 Shares of iRhythm Technologies $IRTC - MarketBeat
Lisanti Capital Growth LLC Makes New Investment in iRhythm Technologies $IRTC - MarketBeat
Here is Why Hedge Funds Are Appreciating iRhythm Holdings (IRTC) - Finviz
Owlet Strengthens Healthcare Partnerships: Can Adoption Scale? - The Globe and Mail
Needham Lifts Price Target on iRhythm Technologies to $254 From $244, Keeps Buy Rating - marketscreener.com
HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - Finviz
EUDA Health (NASDAQ:EUDA) and iRhythm Technologies (NASDAQ:IRTC) Head-To-Head Analysis - Defense World
IRhythm Holdings (NASDAQ:IRTC) Shareholders Are Still up 68% Over 3 Years Despite Pulling Back 3.3% in the Past Week - 富途牛牛
iRhythm Holdings Inc (IRTC) Shares Down 3.76% on Jan 27 - GuruFocus
Did iRhythm's (IRTC) Upgraded 2025–2026 Revenue Outlook Just Shift Its Investment Narrative? - Sahm
iRhythm Technologies (NASDAQ:IRTC) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
iRhythm Technologies (NASDAQ:IRTC) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm - marketscreener.com
Patient Monitoring Stocks Q3 Earnings: iRhythm (NASDAQ:IRTC) Best of the Bunch - Yahoo Finance
iRhythm Technologies $IRTC Shares Sold by Stephens Investment Management Group LLC - MarketBeat
iRhythm Holdings Inc (IRTC) Shares Up 4.41% on Jan 15 - GuruFocus
Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights - marketscreener.com
Inogen (NASDAQ:INGN shareholders incur further losses as stock declines 11% this week, taking five-year losses to 86% - simplywall.st
Is It Time To Rethink iRhythm Holdings (IRTC) After The Recent Share Price Pullback - Yahoo Finance
iRhythm Tech's Stock Selloff Went Too Far After Preliminary Update: Analyst - Benzinga
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC), Charles River Labs (CRL) and Butterfly Network (BFLY) - The Globe and Mail
SG Americas Securities LLC Trims Stock Position in iRhythm Technologies $IRTC - MarketBeat
iRhythm Technologies (NASDAQ:IRTC) Sees Strong Trading Volume Following Analyst Upgrade - Defense World
iRhythm Technologies (IRTC) Expects 2025 Revenue to Exceed $740 Million, 2026 Revenue of $870 Million - Intellectia AI
Aug Volume: Is NeoGenomics Inc stock undervalued right nowQuarterly Profit Summary & Fast Gain Stock Trading Tips - baoquankhu1.vn
iRhythm (IRTC) stock slides as 2026 outlook and holding-company switch land - TechStock²
iRhythm Technologies (NASDAQ:IRTC) Sees Unusually-High Trading Volume Following Analyst Upgrade - MarketBeat
Intel, Salesforce among market cap stock movers on Tuesday - Investing.com
Earnings Miss: Is iRhythm Technologies Inc stock attractive for income investors2025 Fundamental Recap & Weekly Return Optimization Alerts - Bộ Nội Vụ
Oversold Conditions For iRhythm Holdings (IRTC) - Nasdaq
Wells Fargo & Company Forecasts Strong Price Appreciation for iRhythm Technologies (NASDAQ:IRTC) Stock - MarketBeat
Wells Fargo Raises Price Target for iRhythm Technologies (IRTC) - GuruFocus
RSI Check: Will iRhythm Technologies Inc. stock benefit from infrastructure spendingEarnings Performance Report & Weekly Watchlist for Consistent Profits - moha.gov.vn
iRhythm Technologies (IRTC) Is Down 8.6% After Surpassing 2025 Guidance And Turning Free Cash Flow Positive - Sahm
iRhythm Technologies forecasts 17-18% revenue growth for 2026 By Investing.com - Investing.com Nigeria
iRhythm (IRTC) stock drops after JPM update points to $880 million 2026 revenue - TechStock²
Irhythm Technologies, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
Irhythm Holdings Inc Stock (IRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):